VentureBeat

Posts Tagged ‘inv:Jazzya’

Fon, a Spanish startup hoping to build “the world’s largest wireless community”, has raised $9.5 million in a third round of funding, according to TechCrunch.

Coral Capital Management led the round, with participation from British Telecom, Google, Allen & Co., founder Martin Varsavsky’s Jazzya and Joi Ito’s Digital Garage. Varsavsky says he’ll use the new funding to launch Fon in Russia, and to release a new version of the company’s Fonera router.

We covered the company last October, when British Telecom joined Google as a Fon investor. It’s a cool idea: After installing a Fon wireless router, you can open up your network to other Fon users in exchange for free access to other routers when you’re traveling, or you can charge for access and receive 50 percent of the proceeds. But it’s still not clear whether the company is making much money, since it appears to be giving the routers away for free, and the most interesting part of Fon’s model also involves free wireless. (A startup called Meraki is also trying to create a free wireless network, in this case one that envelops San Francisco.)

It’s worth noting that British Telecom and Google may not see Fon as a moneymaker, but as a way to promote their own offerings. Sequoia Capital, a previous Fon investor that’s usually more interested in profit, didn’t participate in the current round.

TODAY’S HEADLINES:

agi-dermatics-logo-150px.gifAGI Dermatics takes in $5M for skincare products – Freeport, N.Y.-based AGI Dermatics, a startup concentrated on skincare products, raised $5 million in a new funding round. Investors included Trevi Health Ventures and Spring Mountain Capital.

AGI makes cosmetic ingredients and is working on developing topical pharmaceutical lotions as well. Its leading drug candidate is called T4N5 Liposome Lotion, which AGI says includes a DNA-repair enzyme intended to repair ultraviolet damage to the skin. The company is currently testing the product as a preventive treatment for skin cancer.

noxxon-logo-150px.gifGermany’s Noxxon gets €1M grant for aptamer drugs — Noxxon, a German biotech aiming to make drugs from nucleic-acid snippets called aptamers, received a grant from Germany’s Federal Ministry of Education and Research. The €1 million ($1.6 million) grant is intended to support Noxxon’s drug-discovery program, which we covered at greater length last May.

myconostica-logo-150px.gifMyconostica raises £3.9M for fungal diagostics – Myconostica, a U.K. biotech that spun out of the University of Manchester, raised £3.9 million ($7.7 million) in a third funding round, GenomeWeb reports. Investors included Amphion Innovations, Nexus Medical Partners, and Innoven Partenaires.

The company is working on rapid diagnostic tests for life-threatening fungal infections. Its first product is a test for several types of fungal infection that is nearing approval in Europe, and which Myconostica thinks could receive U.S. approval by the fourth quarter.

Top Stories

Recent Comments

Powered by Disqus

Featured Guest Columnists

Job Board

Links

Venturebeat Writers

  • For advertising, contact .
  • Log in

Font Size